KHALED A. TAWANSY, M.D., INC
NPI: 1477733822
· LOS ANGELES, CA 90041
· 261Q00000X
$3.95M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
3,326 |
$87K |
| 2019 |
3,960 |
$183K |
| 2020 |
5,050 |
$382K |
| 2021 |
5,975 |
$718K |
| 2022 |
4,369 |
$753K |
| 2023 |
4,206 |
$956K |
| 2024 |
5,684 |
$871K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Aflibercept injection |
1,842 |
1,150 |
$1.68M |
| 67028 |
|
7,796 |
5,044 |
$1.30M |
| J9035 |
Bevacizumab injection |
2,843 |
2,458 |
$219K |
| 99214 |
|
3,214 |
3,000 |
$188K |
| 92134 |
|
5,745 |
5,099 |
$162K |
| 92014 |
|
2,640 |
2,405 |
$152K |
| 76512 |
|
2,434 |
1,609 |
$88K |
| J2777 |
Inj, faricimab-svoa, 0.1mg |
52 |
48 |
$36K |
| 92226 |
|
1,929 |
997 |
$33K |
| 92201 |
|
2,443 |
2,230 |
$31K |
| J7999 |
Compounded drug, noc |
391 |
321 |
$23K |
| 99213 |
|
602 |
577 |
$22K |
| 92012 |
|
88 |
85 |
$7K |
| 92225 |
|
300 |
151 |
$3K |
| 99204 |
|
81 |
81 |
$2K |
| 66984 |
|
13 |
12 |
$2K |
| 99203 |
|
80 |
80 |
$1K |
| 99215 |
Prolong outpt/office vis |
18 |
18 |
$299.30 |
| 92202 |
|
21 |
19 |
$237.67 |
| 92015 |
|
38 |
38 |
$181.85 |